Legal & General Group’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-28,302
Closed -$19.9K 3432
2023
Q1
$19.9K Sell
28,302
-8,056
-22% -$6.63K ﹤0.01% 3067
2022
Q4
$24.9K Hold
36,358
﹤0.01% 3110
2022
Q3
$28K Hold
36,358
﹤0.01% 3119
2022
Q2
$64K Sell
36,358
-22,618
-38% -$48.8K ﹤0.01% 2955
2022
Q1
$196K Buy
58,976
+18,433
+45% +$62.2K ﹤0.01% 2673
2021
Q4
$174K Sell
40,543
-5,420
-12% -$29.3K ﹤0.01% 2768
2021
Q3
$276K Hold
45,963
﹤0.01% 2584
2021
Q2
$378K Sell
45,963
-522
-1% -$4.24K ﹤0.01% 2390
2021
Q1
$380K Buy
46,485
+35,956
+341% +$399K ﹤0.01% 2341
2020
Q4
$128K Buy
10,529
+5,420
+106% +$74.8K ﹤0.01% 2519
2020
Q3
$83K Hold
5,109
﹤0.01% 2536
2020
Q2
$77K Buy
+5,109
New +$69K ﹤0.01% 2600

Other funds holding CGEN

Legal & General Group's CGEN Position: Q2 2023 in Review

Legal & General Group sold out of Compugen (CGEN) in Q2 2023, closing a stake of 28,302 shares — an estimated $19.9K sold.

Legal & General Group first reported a position in CGEN in Q2 2020 and held it in 12 quarters. The position peaked at $380K in Q1 2021. 68 funds tracked by Wall St. Rank hold CGEN as of Q2 2023.

  • Legal & General Group reported no remaining Compugen position as of Q2 2023 after selling out during the quarter.
  • Legal & General Group sold 28,302 Compugen shares in Q2 2023, an estimated $19.9K.
  • Legal & General Group first reported a position in Compugen in Q2 2020 and held it in 12 quarters.
  • Legal & General Group's Compugen position peaked at $380K in Q1 2021.
  • 68 funds tracked by Wall St. Rank held Compugen as of Q2 2023.

Based on Legal & General Group's 13F filing for Q2 2023, filed 14 Aug 2023.